| Dr Talitha Moon, DO, MPH | |
|
Sudlager 301, Apo, AE 92249 | |
| (314) 590-2402 | |
| Not Available |
| Full Name | Dr Talitha Moon |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | Sudlager 301, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003208034 | NPI | - | NPPES |
| 1627 | Other | NE | NEBRASKA MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 1627 (Nebraska) | Primary |
| 208D00000X | General Practice | 1627 (Nebraska) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Talitha Moon, DO, MPH Cmr 411 Box 2481, Apo, AE 09112-0025 Ph: () - | Dr Talitha Moon, DO, MPH Sudlager 301, Apo, AE 92249 Ph: (314) 590-2402 |
News Archive
A new research result from Aarhus University shows that a so-called circular RNA molecule, which has been designated as carcinogenic, is actually not found in the cancer cells. The results have just been published in Nature Communications
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces its unaudited interim results for the six months to 30 June 2009.
› Verified 4 days ago
Dr. Timothy D. Robinette, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86th Mdg Unit 3215, Apo, AE 09094 Phone: 314-480-4675 | |
John William Kieffer, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 3215, Apo, AE 09094 Phone: 637-146-2273 | |
Dr. Donald Walter Robinson, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Hhc, Asg-ku, Attn: Medical, Apo, AE 09366 Phone: 706-239-9678 | |
Dr. Jeffrey Michael Diffenderfer, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-542-3080 | |
Dr. Sonia Leigh Molchan, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: Unit 3215, Apo, AE 09094 Phone: 637-146-2609 | |
Dr. Admirado Adolfo Luzuriaga, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg Unit 3215, Apo, AE 09094 Phone: 004-963-71462609 |